Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7789]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Genetic vs immune strategies in breast cancer
Prof Fabrice André - Institut Gustave Roussy, Paris, France
Genetic vs immune strategies in breast cancer ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )
12 May 2017
Transforming patient care through translational research
Prof Aleix Prat - Hospital Clinic of Barcelona, Barcelona, Spain
Transforming patient care through translational research ( Prof Aleix Prat - Hospital Clinic of Barcelona, Barcelona, Spain )
12 May 2017
Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer
Dr Uzma Asghar - The Institute of Cancer Research, London, UK
Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer ( Dr Uzma Asghar - The Institute of Cancer Research, London, UK )
12 May 2017
pSTAT3 in luminal breast cancer - results from BIG-2-98 trial
Dr Amir Sonnenblick - Hebrew University Medical Center, Jerusalem, Israel
pSTAT3 in luminal breast cancer - results from BIG-2-98 trial ( Dr Amir Sonnenblick - Hebrew University Medical Center, Jerusalem, Israel )
12 May 2017
Adaptive trial design on breast cancer
Prof Laura Vant Veer - University of California San Francisco, San Francisco...
Adaptive trial design on breast cancer ( Prof Laura Vant Veer - University of California San Francisco, San Francisco, USA )
11 May 2017
Discovering genes in mammary cancer by insertional mutagenesis
Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands
Discovering genes in mammary cancer by insertional mutagenesis ( Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands )
27 Apr 2017
Centrosomes in ovarian cancer
Dr Fanni Gergely - CRUK Cambridge Institute
Centrosomes in ovarian cancer ( Dr Fanni Gergely - CRUK Cambridge Institute )
27 Apr 2017
Hallmarks of cancer cell development
Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne...
Hallmarks of cancer cell development ( Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland )
27 Apr 2017
Pembrolizumab and indoximod for melanoma
Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of...
Pembrolizumab and indoximod for melanoma ( Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA )
13 Apr 2017
Projections of cancer incidence and burden among the HIV-positive population in...
Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA
Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030 ( Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA )
12 Apr 2017
Nivolumab for NSCLC: five years on
Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Nivolumab for NSCLC: five years on ( Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
12 Apr 2017
Avelumab for metastatic Merkel cell carcinoma after chemotherapy
Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
Avelumab for metastatic Merkel cell carcinoma after chemotherapy ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA )
12 Apr 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation